SGLT 2 INHIBITORS: NEWER PARADIGMS IN THE TREATMENT OF HEART FAILURE WITH REDUCED EJECTION FRACTION
Journal: International Journal of Advanced Research (Vol.9, No. 11)Publication Date: 2021-11-10
Abstract
Heart Failure is a growing concern now a days. Many drugs are available for the treatment of heart failure but still there is increasing prevalence of heart failure. SGLT 2 inhibitors were initially developed for diabetes mellitus but they are found to be effective for Heart Failure with reduced ejection also. Many large scale randomized controlled trials also confirmed this and now they are recommended in the treatment of heart failure with reduced ejection fraction.
Other Latest Articles
- ONLINE PROBLEM-BASED LEARNING (PBL) DURING CORONAVIRUS PANDEMIC: TRIAL AT THE LIBYAN INTERNATIONAL MEDICAL UNIVERSITY
- SMART WHEELCHAIR/VEHICLE FOR PHYSICALLY CHALLENGED PEOPLE WITH REVERSE GEAR OPERATION
- EFFICACY OF FOUR ESSENTIAL OILS ON FUSARIUM HEAD BLIGHT CAUSED BY FUSARIUM OXYSPORUM F. SP. RADICIS LYCOPERSICI (FORL), A FUNGAL TELLURIC PATHOGEN OF TOMATO GROWN UNDER COVER
- The harmonic and melodic connection numbers involving the mutual inclusions among the generic groups of notes arbitrarily emitted
- The sanitary void of soybeans as a measure to control Asian rust and the importance of official plant health defense actions in this context
Last modified: 2021-12-18 16:19:42